| 영문 | platelet | 한글 | 혈소판 |
|---|---|---|---|
| 설명 | 골수의 거대 세포인 거대핵세포의 세포질 일부가 떨어져서 순환 혈액 중에 출현한 것으로 직경이 2~4μm의 작은 과립체이다. 혈소판은 손상을 입은 혈관의 노출된 결합 조직에 붙어 여러 물질을 분비하여 지혈 및 혈액 응고에 중요한 역할을 한다. |
||
| PA | panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'... |
|---|---|
| ASSC | acute splenic sequestration crisis |
| ELS | Eaton-Lambert syndrome; electron loss spectroscopy; extended least square; extracorporeal life suppo... |
| ILS | idiopathic leucine sensitivity; idiopathic lymphadenopathy syndrome; increase in life span; infrared... |
| PAF | paroxysmal atrial fibrillation; peroxisomal assembly factor; phosphodiesterase-activating factor; pl... |
| PS | Pulmonary sequestration |
|---|---|
| PRP | 1--Platelet-rich plasma |
| APS | Anti-platelet serum |
| PDGF | Anti-platelet-derived growth factor |
| GPS | Gray platelet syndrome |
| bronchopulmonary sequestration | A developmental anomaly in which a mass of nonfunctioning lung tissue lacks normal connection with the tracheobroncheal tree and receives an anomalous blood supply originating from the descending thoracic or abdominal aorta. The mass may be extralobar, i.e., completely separated from normally connected lung, or intralobar, i.e., partly surrounded by normal lung. (12 Dec 1998) |
|---|---|
| sequestration | 1. Formation of a sequestrum. 2. Loss of blood or of its fluid content into spaces within the body so that it is withdrawn from the circulating volume, resulting in haemodynamic impairment, hypovolaemia, hypotension, and reduced venous return to the heart. Origin: L. Sequestratio, fr. Sequestro, pp. -atus, to lay aside (05 Mar 2000) |
| sequestration cyst | A collection of cancerous cells which form cysts that contain one or more of the three primary embryonic germ layers: skin, hair or teeth. (27 Sep 1997) |
| sequestration dermoid | An obsolete term for epidermal cyst. (05 Mar 2000) |
| disc sequestration | <radiology> Complete separation of disc material with rupture through posterior longitudinal ligament into the epidural space; free fragment herniation findings: migration superiorly/inferiorly with compression of nerve roots above/below the level of herniation, disc material noted more than 9mm from disc space Differential diagnosis: postoperative scarring (retraction of thecal sac to the site of surgery), epidural abscess/tumour, conjoined nerve root: 2 nerve roots arising simultaneously from the thecal sac; normal variant in 1-3% see: degenerative disc disease (12 Dec 1998) |
| intralobar sequestration | <radiology> Nonfunctioning portion of lung <indent>WITHIN visceral pleura of a pulmonary lobe, left lower lobe (67%); rarely in upper lobes, arterial supply: SYSTEMIC, usually aorta, venous drainage: usually via pulmonary. Vv. (occasionally systemic), usually does not communicate with bronchial tree, cystic, may become infected, not associated with other abnormalities see: sequestration Cf: extralobar sequestration (12 Dec 1998) |
| extralobar sequestration | <radiology> Accessory lung: lung tissue in its own pleura, left lower lobe (90%), systemic arterial AND venous connection (unlike intralobar) results in L to R shunt, associated with congenital anomalies of diaphragm: eventration, paralysis, ipsilateral hernia, XR: homogeneous ST mass, rarely infected see also: sequestration Cf: intralobar sequestration (12 Dec 1998) |
| acquired platelet function defect | <haematology> Platelet function can be affected by a number of different disease processes including polycythaemia vera, leukaemia, myelofibrosis, renal failure, multiple myeloma and some medications (for example penicillins, salicylates, phenothiazines). Disturbed blood clotting can be manifested by: easy bruising, bleeding gums, nosebleeds, abnormal vaginal bleeding, rectal bleeding, skin rash, vomiting blood, coughing up blood or blood in the urine. A measure of bleeding time and coagulation profile will be part of the evaluation. (29 Dec 1997) |
| antigens, human platelet | Human alloantigens expressed only on platelets, specifically on platelet membrane glycoproteins. These platelet-specific antigens are immunogenic and can result in pathological reactions to transfusion therapy. (12 Dec 1998) |
| anti-platelet agents | Medications that, like aspirin, reduce the tendency of platelets in the blood to clump and clot. (12 Dec 1998) |
| receptors, platelet-derived growth factor | Specific molecular sites or structures on cell membranes that react with platelet-derived growth factor, its analogs, or antagonists, to elicit or to inhibit the specific response of the cell to this factor. Pdgf binds with different affinities and specificities to two structurally related receptors, the alpha-receptor and the beta-receptor. Both of these receptors are transmembrane proteins with an intracellular, ligand-stimulatable protein kinase domain. (12 Dec 1998) |
| medication, anti-platelet | Platelet-blocking drugs. Drugs that, like aspirin, reduce the tendency of platelets in the blood to clump and clot. (12 Dec 1998) |
| platelet | <haematology> A discoid cell (3m diameter) found in large numbers in blood, important for blood coagulation and for haemostasis by repairing breaches (small breaks) in the walls of blood vessels. Platelet _ granules contain lysosomal enzymes, dense granules contain ADP (a potent platelet aggregating factor) and serotonin (a vasoactive amine). They also release platelet-derived growth factor which presumably contributes to later repair processes by stimulating fibroblast proliferation. Synonym: thrombocytes. (09 Oct 1997) |
| platelet-activating factor | <cytokine> Potent phospholipid activator and mediator of many leucocyte functions, including platelet aggregation, inflammation, and anaphylaxis. It is produced in response to specific stimuli by a variety of cell types, including neutrophils, basophils, platelets, and endothelial cells. Several molecular species of platelet-activating factor have been identified which vary in the length of the O-alkyl side chain. It is an important mediator of bronchoconstriction. Synonym: platelet-aggregating factor. Acronym: PAF (20 Sep 2002) |
| platelet activation | A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable haemostatic plug. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|